Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RARγ degradation and transactivation

EMBO Journal

Volumn 21, Issue 14, 2002, Pages 3760-3769

  Giannì, Maurizio ^a   Bauer, Annie ^a   Garattini, Enrico ^a   Chambon, Pierre ^a   Rochette Egly, Cécile ^a  

^a Centre de Recherche Interdisciplinaire en Biologie   (France)

Author keywords

Degradation; p38MAPK; Phosphorylation; Proteasome; RAR ; Transcription

Indexed keywords

CELL NUCLEUS RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPEPTIDE; PROTEASOME; PROTEASOME SUG 1; RETINOIC ACID; RETINOIC ACID RECEPTOR GAMMA; RNA; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CARRIER PROTEINS; COS CELLS; CYSTEINE ENDOPEPTIDASES; LIGANDS; MITOGEN-ACTIVATED PROTEIN KINASES; MULTIENZYME COMPLEXES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, RETINOIC ACID; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRETINOIN; UBIQUITIN;

ANIMALIA;

EID: 0037099584     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdf374     Document Type: Article

References (56)

1. Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid
2. TFIIH interacts with the retinoic acid receptor γ and phosphorylates its AF-1-activating domain through cdk7
3. Cyclin D1 proteolysis: A retinoid chemoprevention signal in normal, immortalized and transformed human bronchial epithelial cells
4. A decade of molecular biology on retinoic acid receptors
5. Steroid/nuclear receptor coactivators
6. Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells
7. RXRα-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids
8. Dissection of protein kinase cascades that mediate cellular response to cytokines and cellular stress
9. The proteasome, a novel protease regulated by multiple mechanisms
10. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription
11. The 14th Datta Lecture. TFIIH: From transcription to clinic
12. Thermolability of ubiquitin-activating enzyme from the mammalian cell cycle mutant ts85
13. SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase
14. Stability of the ATF2 transcription factor is regulated by phosphorylation and dephosphorylation
15. The coregulator exchange in transcriptional functions of nuclear receptors
16. The regulatory particle of the Saccharomyces cerevisiae proteasome
17. Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation
18. Ubiquitin, proteasomes and the regulation of intracellular protein degradation
19. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life?
20. XPD mtation prevents TFIIH-dependent phosphorylation of nuclear receptors and transactivation
21. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway
22. Substrate targeting in the ubiquitin system
23. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome
24. The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation
25. The RXR heterodimers and orphan receptors
26. A genetic dissection of the retinoid signalling pathway in the mouse
27. Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the AF-2 domain of VDR
28. Ubiquitylation of RNA polymerase II large subunit signaled by phosphorylation of C-terminal domain
29. Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo
30. The nuclear receptor ligand- binding domain: Structure and function
31. Cyclin-dependent kinases: Engines, clocks and microprocessors
32. Transcriptional coactivator complexes
33. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors
34. PARs and RXRs: Evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo
35. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin
36. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions
37. The conserved amphipatic α-helical core motif of RARγ and RARα activating domains is indispensable for RA-induced differentiation of F9 cells
38. F9 embryocarcinoma cells: A cell autonomous model to study the functional selectivity of RARs and RXRs in retinoid signaling
39. Retinoic acid receptor gamma: Specific immunodetection and phosphorylation
40. Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies
41. Phosphorylation of the retinoic acid receptor-α by protein kinase A
42. Stimulation of RARα activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7
43. Identification of the ga4 suppressor Sug1 as a subunit of the yeast 26S proteasome
44. Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize Myc
45. Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis
46. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294
47. Phosphorylation of activation functions AF-1 and AF-2 of RARα and RARγ is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment
48. Transcriptional activation: Risky business
49. Transcriptional regulation: Kamikaze activators
50. The human estrogen receptor has two independent nonacidic transcriptional activation functions
51. Residues phosphorylated by TFIIH are required for E2F-1 degradation during S-phase
52. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and-independent pathways
53. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUGI and TIF1
54. The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG-1, a subunit of the 26S proteasome and putative transcription factor
55. The acidic transcriptional activator Gal-VP16 acts on preformed template-commited complexes
56. The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists and selective estrogen receptor modulators